Bharat Hegde
Fund manager Bharat Hegde: portfolio changes across the 1 scheme AMFI's scheme summary documents name them on, Oct 2026, by share count.
Equity.
1 with AMFI average AUM, July - September 2026; each scheme in full, not split between co-managers. Source: AMFI.
On a scheme named on today, as the fund house files it. Source: AMFI SSD.
People named on at least one of the same schemes.
| Scheme | Fund house | Category | AUM | Role, as filed | Since, as filed | As of |
|---|---|---|---|---|---|---|
| Bajaj Finserv Healthcare Fund | Bajaj Finserv Mutual Fund | Equity Scheme - Sectoral/ Thematic | ₹389 cr | — | — | 3 Nov 2026 |
From each scheme's summary document on AMFI's site (scheme details), as it stood on the date shown. How to read
Named on the same scheme's summary document; the number is how many schemes they share. Source: AMFI SSD.
- ₹36.7 cr
- ₹35.5 cr
- ₹29.8 cr
- ₹27.0 cr
- ₹24.6 cr
- ₹24.5 cr
- ₹19.2 cr
- ₹18.6 cr
- ₹16.6 cr
- ₹15.7 cr
| Ticker | Company | Value | % of equity held | Schemes holding |
|---|---|---|---|---|
| DIVISLAB | Divi's Laboratories Limited | ₹36.7 cr | 9.2 % | 1 |
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹35.5 cr | 8.9 % | 1 |
| PPLPHARMA | Piramal Pharma Limited | ₹29.8 cr | 7.5 % | 1 |
| APOLLOHOSP | Apollo Hospitals Enterprise Limited | ₹27.0 cr | 6.8 % | 1 |
| AUROPHARMA | Aurobindo Pharma Limited | ₹24.6 cr | 6.1 % | 1 |
| RUBICON | Rubicon Research Limited | ₹24.5 cr | 6.1 % | 1 |
| LAURUSLABS | Laurus Labs Limited | ₹19.2 cr | 4.8 % | 1 |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹18.6 cr | 4.7 % | 1 |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹16.6 cr | 4.2 % | 1 |
| EMCURE | Emcure Pharmaceuticals Limited | ₹15.7 cr | 3.9 % | 1 |
| NEULANDLAB | Neuland Laboratories Limited | ₹14.3 cr | 3.6 % | 1 |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹12.3 cr | 3.1 % | 1 |
| ALKEM | Alkem Laboratories Limited | ₹11.9 cr | 3.0 % | 1 |
| MAXHEALTH | Max Healthcare Institute Limited | ₹11.2 cr | 2.8 % | 1 |
| IPCALAB | IPCA Laboratories Limited | ₹9.7 cr | 2.4 % | 1 |
The 15 largest holdings by market value, summed over the schemes this manager is named on today.
1 scheme has no filed start date, so no return is shown
Each scheme's direct-growth return over the dates filed for this manager, next to its category's average. Returns and averages are computed by this site from AMFI NAVs; they are not the fund house's figures. Past performance may not be sustained in future.
| Month | Schemes with a change | Stocks added | Stocks cut | Bought | Sold | Net |
|---|---|---|---|---|---|---|
| Oct 2026 | 1 | 3 | 2 | ₹15.5 cr | ₹5.9 cr | +₹9.6 cr |
| Sep 2026 | 1 | 3 | 4 | ₹23.8 cr | ₹7.8 cr | +₹15.9 cr |
| Aug 2026 | 1 | 3 | 2 | ₹11.7 cr | ₹8.1 cr | +₹3.6 cr |
| Jul 2026 | 1 | 4 | 4 | ₹19.1 cr | ₹14.9 cr | +₹4.2 cr |
| Jun 2026 | 1 | 8 | 3 | ₹6.1 cr | ₹3.8 cr | +₹2.3 cr |
| May 2026 | 1 | 4 | 5 | ₹13.3 cr | ₹21.4 cr | −₹8.1 cr |
| Apr 2026 | 1 | 1 | 0 | ₹2.7 cr | ₹0.00 cr | +₹2.7 cr |
| Mar 2026 | 1 | 4 | 6 | ₹7.1 cr | ₹16.9 cr | −₹9.7 cr |
| Feb 2026 | 1 | 7 | 6 | ₹43.8 cr | ₹30.7 cr | +₹13.2 cr |
| Jan 2026 | 1 | 1 | 4 | ₹0.48 cr | ₹12.5 cr | −₹12.0 cr |
| Dec 2025 | 1 | 6 | 1 | ₹8.8 cr | ₹5.9 cr | +₹2.9 cr |
| Nov 2025 | 1 | 5 | 5 | ₹18.6 cr | ₹15.9 cr | +₹2.7 cr |
Across the schemes this manager is named on today, by share count.
Changes seen in AMFI's documents
since 29 Sep 2026
Changes on this manager's schemes, by the date AMFI's document first showed them.
Added 3
3 stocks · largest 3 by value
| Stock | Schemes | Implied change, share count × price | Price 30 Oct 2026, 12‑month change |
|---|---|---|---|
| DRREDDY | 1 | +₹10.5 cr | ₹1,352.00 ▲ +12.9% |
| APOLLOHOSP | 1 | +₹3.9 cr | ₹8,448.00 ▲ +10.0% |
| ZYDUSLIFE | 1 | +₹1.1 cr | ₹1,245.50 ▲ +27.8% |
Cut 2
2 stocks · largest 2 by value
| Stock | Schemes | Implied change, share count × price | Price 30 Oct 2026, 12‑month change |
|---|---|---|---|
| DIVISLAB | 1 | −₹4.9 cr | ₹9,780.00 ▲ +45.1% |
| MEDIASSIST | 1 | −₹1.00 cr | ₹295.20 ▼ −48.2% |
Each scheme's change in shares at its month-end price, summed over this manager's schemes, Oct 2026.
Questions about Bharat Hegde
from the figures on this pageWhat stocks are in Bharat Hegde's portfolio?
The 1 scheme Bharat Hegde manages held 33 stocks worth ₹400 cr at Oct 2026 end. Largest: Divi's Laboratories 9.2 %, Sun Pharmaceutical Industries 8.9 %, Piramal Pharma 7.5 %, Apollo Hospitals Enterprise 6.8 %, Aurobindo Pharma 6.1 %. Divi's Laboratories mutual fund holdings · Sun Pharmaceutical Industries mutual fund holdings · Piramal Pharma mutual fund holdings
Which stocks did Bharat Hegde buy and sell in Oct 2026?
In Oct 2026, Bharat Hegde's schemes added to 3 stocks, largest Dr. Reddy's Laboratories (DRREDDY), Apollo Hospitals Enterprise (APOLLOHOSP), Zydus Lifesciences (ZYDUSLIFE); cut 2, largest Divi's Laboratories (DIVISLAB), Medi Assist Healthcare Services (MEDIASSIST), by value at month-end prices.
Which mutual fund schemes does Bharat Hegde manage?
AMFI's scheme summary documents name Bharat Hegde (Bajaj Finserv Mutual Fund) for 1 scheme: Bajaj Finserv Healthcare Fund. Bajaj Finserv Healthcare Fund portfolio